Similar articles

• [Long-term hormone replacement and risk of breast carcinoma: current status. On behalf of the German Menopause Society and the Professional Society of Gynecologic Endocrinology and Reproductive Medicine of the German Society of Gynecology and Obstetrics].

  Kuhl H, Runnebaum B, Schneider HP. Kuhl H, et al. Zentralbl Gynakol. 1995;117(10):549-53. Zentralbl Gynakol. 1995. PMID: 7491838 Review. German. No abstract available.
• [Hepatic changes in different hormone replacement therapies in climacteric].

  Foth D, Römer T, Panzig E. Foth D, et al. Zentralbl Gynakol. 1995;117(7):349-52. Zentralbl Gynakol. 1995. PMID: 7668064 German.
• Estrogens and progestins: what to use and how to use it.

  Jones KP. Jones KP. Clin Obstet Gynecol. 1992 Dec;35(4):871-83. Clin Obstet Gynecol. 1992. PMID: 1451370 Review. No abstract available.
• [Estrogens in menopause--therapy and prevention. II. Estrogens and osteoporosis].

  Hüfner M. Hüfner M. Internist (Berl). 1996 Apr;37(4):405-9. Internist (Berl). 1996. PMID: 8655281 Review. German. No abstract available.
• [Effect of hormone substitution therapy on AT III in women in the climacteric].

  Enzelsberger H, Heytmanek H, Kurz C, Metka M. Enzelsberger H, et al. Zentralbl Gynakol. 1991;113(11):639-44. Zentralbl Gynakol. 1991. PMID: 1656654 German.